Carroll Financial Associates’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-18
| Closed | -$2K | – | 1618 |
|
|
2020
Q2 | $2K | Sell |
18
-200
| -92% | -$22.2K | ﹤0.01% | 1364 |
|
|
2020
Q1 | $18K | Buy |
218
+200
| +1,111% | +$16.5K | ﹤0.01% | 805 |
|
|
2019
Q4 | $1K | Hold |
18
| – | – | ﹤0.01% | 1458 |
|
|
2019
Q3 | $1K | Hold |
18
| – | – | ﹤0.01% | 1432 |
|
|
2019
Q2 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 1483 |
|